Scientific Ind Financials
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Scientific Ind has an operating margin of -62.0%, meaning the company retains $-62 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -83.3% the prior year.
Scientific Ind's revenue declined 3.6% year-over-year, from $11.1M to $10.7M. This contraction results in a growth score of 18/100.
Scientific Ind carries a low D/E ratio of 0.27, meaning only $0.27 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 4.74, Scientific Ind holds $4.74 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
While Scientific Ind generated -$3.7M in operating cash flow, capex of $99K consumed most of it, leaving -$3.8M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Scientific Ind passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.
For every $1 of reported earnings, Scientific Ind generates $0.57 in operating cash flow (-$3.7M OCF vs -$6.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
This page shows Scientific Ind (SCND) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Key Financial Metrics
Scientific Ind generated $10.7M in revenue in fiscal year 2024. This represents a decrease of 3.6% from the prior year.
Scientific Ind's EBITDA was -$5.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 30.8% from the prior year.
Scientific Ind generated -$3.8M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 39.8% from the prior year.
Scientific Ind reported -$6.4M in net income in fiscal year 2024. This represents an increase of 29.1% from the prior year.
Scientific Ind earned $-0.61 per diluted share (EPS) in fiscal year 2024. This represents an increase of 52.0% from the prior year.
Scientific Ind held $588K in cash against $0 in long-term debt as of fiscal year 2024.
Scientific Ind had 12M shares outstanding in fiscal year 2024. This represents an increase of 17.6% from the prior year.
Scientific Ind's gross margin was 44.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the prior year.
Scientific Ind's operating margin was -62.0% in fiscal year 2024, reflecting core business profitability. This is up 21.4 percentage points from the prior year.
Scientific Ind's net profit margin was -60.2% in fiscal year 2024, showing the share of revenue converted to profit. This is up 21.6 percentage points from the prior year.
Scientific Ind invested $2.9M in research and development in fiscal year 2024. This represents a decrease of 18.5% from the prior year.
Scientific Ind invested $99K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 24.9% from the prior year.
SCND Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M-39.7% | $2.3M-3.2% | $2.4M-43.3% | $4.2M+60.4% | $2.6M+6.6% | $2.5M-9.3% | $2.7M+5.9% | $2.6M |
| Cost of Revenue | $765K-41.6% | $1.3M-5.7% | $1.4M-45.0% | $2.5M+86.5% | $1.4M-6.1% | $1.4M-4.1% | $1.5M+7.2% | $1.4M |
| Gross Profit | $639K-37.4% | $1.0M+0.3% | $1.0M-40.9% | $1.7M+33.1% | $1.3M+24.2% | $1.0M-15.6% | $1.2M+4.4% | $1.2M |
| R&D Expenses | $621K-8.2% | $677K+3.9% | $652K-26.4% | $885K+32.9% | $666K-6.3% | $711K-40.5% | $1.2M+33.3% | $896K |
| SG&A Expenses | $804K-17.6% | $976K-22.0% | $1.3M-14.2% | $1.5M+37.3% | $1.1M-30.2% | $1.5M-7.9% | $1.7M+84.4% | $896K |
| Operating Income | -$1.5M+1.5% | -$1.5M+14.7% | -$1.8M-10.0% | -$1.6M-23.2% | -$1.3M+36.1% | -$2.1M+10.7% | -$2.3M-5.2% | -$2.2M |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | $0 | $0 | $0 | $0+100.0% | -$109K | $0 |
| Net Income | $4.0M+362.3% | -$1.5M+14.4% | -$1.8M+7.9% | -$1.9M-50.4% | -$1.3M+37.4% | -$2.1M+7.7% | -$2.2M-1.0% | -$2.2M |
| EPS (Diluted) | $0.34+361.5% | $-0.13-181.3% | $0.16+127.6% | $-0.58-383.3% | $-0.12-160.0% | $0.20 | N/A | $-0.31 |
SCND Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $14.6M+42.4% | $10.2M-3.3% | $10.6M-8.6% | $11.6M-19.0% | $14.3M-8.2% | $15.5M-7.1% | $16.7M+28.2% | $13.0M |
| Current Assets | $11.9M+64.9% | $7.2M-2.5% | $7.4M-10.8% | $8.3M-20.2% | $10.4M-8.9% | $11.4M-7.6% | $12.3M+44.0% | $8.6M |
| Cash & Equivalents | $1.2M+30.4% | $891K+89.6% | $470K-20.0% | $588K+4.9% | $561K+59.4% | $352K-55.8% | $796K+54.5% | $515K |
| Inventory | $2.0M-53.5% | $4.4M+0.9% | $4.4M+111.4% | $2.1M-61.8% | $5.4M+10.8% | $4.9M-0.3% | $4.9M-7.5% | $5.3M |
| Accounts Receivable | $678K-29.9% | $966K-20.0% | $1.2M+104.9% | $589K-51.5% | $1.2M+6.1% | $1.1M-1.1% | $1.2M-10.5% | $1.3M |
| Goodwill | $115K0.0% | $115K0.0% | $115K0.0% | $115K0.0% | $115K0.0% | $115K0.0% | $115K0.0% | $115K |
| Total Liabilities | $2.1M-6.1% | $2.2M-20.4% | $2.8M+14.8% | $2.4M-5.9% | $2.6M-11.4% | $2.9M+2.9% | $2.8M-10.3% | $3.2M |
| Current Liabilities | $1.6M-8.4% | $1.7M-20.5% | $2.1M+22.1% | $1.7M-1.5% | $1.8M-13.5% | $2.1M+11.6% | $1.8M-15.8% | $2.2M |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $12.5M+57.3% | $7.9M+2.0% | $7.8M-14.8% | $9.1M-21.9% | $11.7M-7.4% | $12.6M-9.1% | $13.9M+40.6% | $9.9M |
| Retained Earnings | -$33.2M+10.7% | -$37.2M-4.3% | -$35.7M-205.2% | $33.9M+210.1% | -$30.8M-4.3% | -$29.5M-7.5% | -$27.5M-8.8% | -$25.3M |
SCND Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$1.6M-13.7% | -$1.4M-7.6% | -$1.3M-364.9% | $503K+157.6% | -$872K+44.3% | -$1.6M-17.4% | -$1.3M-14.8% | -$1.2M |
| Capital Expenditures | $10K+50.7% | $7K-73.8% | $26K+14.8% | $23K-7.3% | $25K-48.0% | $48K+244.2% | $14K+17.9% | $12K |
| Free Cash Flow | -$1.6M-13.9% | -$1.4M-6.0% | -$1.4M-383.0% | $480K+153.5% | -$896K+44.4% | -$1.6M-19.7% | -$1.3M-14.8% | -$1.2M |
| Investing Cash Flow | $864K+129.3% | $377K-68.7% | $1.2M+176.1% | $436K-60.0% | $1.1M+126.8% | $481K+111.6% | -$4.1M-502.3% | $1.0M |
| Financing Cash Flow | $500K-65.6% | $1.5M | $0 | $0 | $0-100.0% | $646K-88.7% | $5.7M+43042.1% | $13K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
SCND Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.5%+1.7pp | 43.8%+1.5pp | 42.2%+1.7pp | 40.5%-8.3pp | 48.8%+6.9pp | 41.9%-3.1pp | 45.0%-0.7pp | 45.7% |
| Operating Margin | -108.4%-42.1pp | -66.3%+8.9pp | -75.3%-36.5pp | -38.8%+11.7pp | -50.5%+33.7pp | -84.1%+1.3pp | -85.5%+0.6pp | -86.1% |
| Net Margin | 284.5%+349.9pp | -65.3%+8.6pp | -73.9%-28.5pp | -45.4%+3.0pp | -48.5%+34.1pp | -82.6%-1.4pp | -81.2%+3.9pp | -85.1% |
| Return on Equity | 32.0% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | 27.4%+42.3pp | -14.9%+1.9pp | -16.8%-0.1pp | -16.7%-7.7pp | -9.0%+4.2pp | -13.2%+0.1pp | -13.3%+3.6pp | -16.9% |
| Current Ratio | 7.65+3.4 | 4.25+0.8 | 3.47-1.3 | 4.74-1.1 | 5.85+0.3 | 5.56-1.2 | 6.72+2.8 | 3.93 |
| Debt-to-Equity | 0.17-0.1 | 0.28-0.1 | 0.36+0.1 | 0.27+0.0 | 0.22-0.0 | 0.23+0.0 | 0.20-0.1 | 0.32 |
| FCF Margin | -116.7%-54.9pp | -61.8%-5.3pp | -56.4%-67.7pp | 11.3%+45.1pp | -33.9%+31.1pp | -64.9%-15.7pp | -49.2%-3.8pp | -45.4% |
Similar Companies
Frequently Asked Questions
What is Scientific Ind's annual revenue?
Scientific Ind (SCND) reported $10.7M in total revenue for fiscal year 2024. This represents a -3.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Scientific Ind's revenue growing?
Scientific Ind (SCND) revenue declined by 3.6% year-over-year, from $11.1M to $10.7M in fiscal year 2024.
Is Scientific Ind profitable?
No, Scientific Ind (SCND) reported a net income of -$6.4M in fiscal year 2024, with a net profit margin of -60.2%.
What is Scientific Ind's earnings per share (EPS)?
Scientific Ind (SCND) reported diluted earnings per share of $-0.61 for fiscal year 2024. This represents a 52.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Scientific Ind's EBITDA?
Scientific Ind (SCND) had EBITDA of -$5.9M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
What is Scientific Ind's gross margin?
Scientific Ind (SCND) had a gross margin of 44.2% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Scientific Ind's operating margin?
Scientific Ind (SCND) had an operating margin of -62.0% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
What is Scientific Ind's net profit margin?
Scientific Ind (SCND) had a net profit margin of -60.2% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Scientific Ind's free cash flow?
Scientific Ind (SCND) generated -$3.8M in free cash flow during fiscal year 2024. This represents a 39.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Scientific Ind's operating cash flow?
Scientific Ind (SCND) generated -$3.7M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Scientific Ind's total assets?
Scientific Ind (SCND) had $11.6M in total assets as of fiscal year 2024, including both current and long-term assets.
What are Scientific Ind's capital expenditures?
Scientific Ind (SCND) invested $99K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Scientific Ind spend on research and development?
Scientific Ind (SCND) invested $2.9M in research and development during fiscal year 2024.
How many shares does Scientific Ind have outstanding?
Scientific Ind (SCND) had 12M shares outstanding as of fiscal year 2024.
What is Scientific Ind's current ratio?
Scientific Ind (SCND) had a current ratio of 4.74 as of fiscal year 2024, which is generally considered healthy.
What is Scientific Ind's debt-to-equity ratio?
Scientific Ind (SCND) had a debt-to-equity ratio of 0.27 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Scientific Ind's return on assets (ROA)?
Scientific Ind (SCND) had a return on assets of -55.8% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Scientific Ind's cash runway?
Based on fiscal year 2024 data, Scientific Ind (SCND) had $588K in cash against an annual operating cash burn of $3.7M. This gives an estimated cash runway of approximately 2 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
What is Scientific Ind's Piotroski F-Score?
Scientific Ind (SCND) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Scientific Ind's earnings high quality?
Scientific Ind (SCND) has an earnings quality ratio of 0.57x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Scientific Ind?
Scientific Ind (SCND) scores 44 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.